Ziccum CEO Analyst video interview: Q2, 2024 highlights - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Läs mer: Investera i räntebärande lån – Historisk årlig avkastning på 9,9 % (annons)

Pressmeddelande

Ziccum CEO Analyst video interview: Q2, 2024 highlights

MFN Publicerad: 05 Sep 10:00
Ziccum

Watch Ziccum CEO Ann Gidner in a comprehensive interview in Swedish with analyst Jonathan Furelid on the highlights of Ziccum’s Q2 2024 report and the company’s current and coming status.

CEO Ann Gidner provides investors with updates and insights on further mRNA/LNP milestones, including the recently disclosed significant mRNA activity increase with LaminarPace, the status of Ziccum’s current partner projects including the newly signed ReCode Therapeutics deal, the growing industry-wide interest for Ziccum and the progress in solidifying Ziccum’s intellectual property protection.

You may watch the interview here: https://youtu.be/6ttsdxZh6UM

For more information about Ziccum, please contact:

Ann Gidner
CEO, Ziccum AB
Mail: [email protected]
Mobile: +46 722140141

Jonas Ekblom
Chairman of the Board, Ziccum AB
Mail: [email protected]
Mobile: +46 736777540

Ziccum’s Certified Adviser is
Carnegie Investment Bank AB (publ)
Follow us on https://eucaps.com/ziccum

About Ziccum

Ziccum is developing LaminarPaceTM, a unique drying method for biopharmaceuticals and vaccines based on mass transfer, not heat transfer. The technology is offered by licensing to vaccine and biologics developers and manufacturers in the global pharmaceutical industry. By reducing drying stress to the active ingredient, LaminarPaceTM uniquely enables particle-engineered, thermostable dry powder biopharmaceuticals which can be easily handled and transported and are highly suitable for novel administration routes. The technology has been successfully applied to mRNA, peptides, proteins, antibodies, lipids and enzymes as well as excipients and adjuvants, and is well suited for industrial application. Ziccum is listed on the Nasdaq First North Growth Market.

Attachments

Ziccum CEO Analyst video interview: Q2, 2024 highlights

Bifogade filer

Ziccum CEO Analyst video interview: Q2, 2024 highlightshttps://storage.mfn.se/b7eafcbe-1091-450f-88cb-8a601f1d2951/ziccum-ceo-analyst-video-interview-q2-2024-highlights.pdf

Nyheter om Ziccum

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

Jämförelse: Vilken är Sveriges bästa fondrobot?Guide: Så börjar du spara i fonder som nybörjareTopplistor: Fonderna med bäst avkastning just nu
STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Ziccum

Senaste nytt